BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23197229)

  • 1. Optimizing HgA1C and glucose monitoring frequency in patients with Type 2 diabetes.
    Bridges JF; Brignac D; Thomas S; Kent C; Ogbuli M; Draper J; Rasumssen H; Daniels A; Cook D; Chartier C; Brewer L; Mesak H
    Med Sci Monit; 2012 Dec; 18(12):CR693-7. PubMed ID: 23197229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
    Harris MI;
    Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Family Medicine and General Internal Medicine on Diabetes Management.
    Zoberi KA; Salas J; Morgan CN; Scherrer JF
    Mo Med; 2017; 114(3):187-194. PubMed ID: 30228578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of glycaemia control in subjects with type 2 diabetes by self-monitoring of blood glucose: comparison of two management programs adjusting bedtime insulin dosage.
    Chen HS; Wu TE; Jap TS; Lin SH; Hsiao LC; Lin HD
    Diabetes Obes Metab; 2008 Jan; 10(1):34-40. PubMed ID: 18095948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Hoffman RM; Duckworth WC; Wendel CS; Shah JH;
    Am J Med Sci; 2004 Jun; 327(6):319-23. PubMed ID: 15201644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of self-monitoring and its effect on metabolic control in patients with type 2 diabetes.
    Jaworska J; Dziemidok P; Kulik TB; Rudnicka-Drozak E
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):310-6. PubMed ID: 16146003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events.
    Farmer A; Balman E; Gadsby R; Moffatt J; Cradock S; McEwen L; Jameson K
    Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
    Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
    Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
    Ziegler R; Eichholz R; Schulz B
    J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.
    Elliott T; Beca S; Beharry R; Tsoukas MA; Zarruk A; Abitbol A
    Diab Vasc Dis Res; 2021; 18(4):14791641211021374. PubMed ID: 34275385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC).
    Kleefstra N; Hortensius J; Logtenberg SJ; Slingerland RJ; Groenier KH; Houweling ST; Gans RO; van Ballegooie E; Bilo HJ
    Neth J Med; 2010 Aug; 68(1):311-6. PubMed ID: 20739728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry.
    Karter AJ; Ackerson LM; Darbinian JA; D'Agostino RB; Ferrara A; Liu J; Selby JV
    Am J Med; 2001 Jul; 111(1):1-9. PubMed ID: 11448654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus.
    Tildesley HD; Wright AM; Chan JH; Mazanderani AB; Ross SA; Tildesley HG; Lee AM; Tang TS; White AS
    Can J Diabetes; 2013 Oct; 37(5):305-8. PubMed ID: 24500556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study.
    Bergenstal RM; Bode BW; Tamler R; Trence DL; Stenger P; Schachner HC; Fullam J; Pardo S; Kohut T; Fisher WA
    Diabetes Technol Ther; 2012 Oct; 14(10):851-7. PubMed ID: 23013200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Glucose Monitoring in Patients With Type 2 Diabetes.
    Ann Intern Med; 2017 Sep; 167(6):. PubMed ID: 28828488
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.